Continuing Education For Healthcare Professionals
FreeCE | PharmCon | Support | Forums | Blogs | Contact Us
Log In
 
 
Forgot Your Password
 
Facebook Twitter Blogs RSS feeds Forums
 
 
 
Skip Navigation Links > FreeCE > Catalog of Homestudy CE > Program Details
 
Treating Breakthrough Cancer Pain - What Pharmacists Need to Know
Continuing Education Credits for Healthcare Professionals
Credits
1.5 Contact Hours

Event Type
Home Study Webcast

Release Date
Thursday, January 20, 2011

Expiration Date
Thursday, June 20, 2013

Target Audience
Nurse, Pharmacist

Program Cost
$3.00 - Free For Members



Program Overview
Pain is one of the most common, yet misunderstood and feared symptoms of cancer. Breakthrough cancer pain when left untreated significantly impacts quality of life. The treatments available for breakthrough cancer pain require health care providers and pharmacists in particular to pay strict attention to REMS process set up by pharmaceutical companies. This program will enhance the pharmacists' understanding of breakthrough cancer pain, provide pharmacists with an overview of the pain medications available for opioid tolerant cancer patients with breakthrough cancer pain, describe the REMS processes, delineate strategies, and mitigate the risk of abuse and misuse of these pain medications.

Nurse Educational Objectives
  • Describe the etiology and epidemiology of breakthrough cancer pain in opioid tolerant cancer patients.
  • Outline the concept of opioid tolerance.
  • Review FDA approved pharmacological treatments for opioid tolerant breakthrough cancer pain to include patient selection, pharmacologic profiles, efficacy, side effects, and adverse effects.
  • Describe practical strategies to mitigate the risk of overdose, abuse, addiction, and diversion and minimize medication errors to protect patients and pharmacy.
Pharmacist Educational Objectives
  • Describe the etiology and epidemiology of breakthrough cancer pain in opioid tolerant cancer patients.
  • Outline the concept of opioid tolerance.
  • Review FDA approved pharmacological treatments for opioid tolerant breakthrough cancer pain to include patient selection, pharmacologic profiles, efficacy, side effects, and adverse effects.
  • Describe practical strategies to mitigate the risk of overdose, abuse, addiction, and diversion and minimize medication errors to protect patients and pharmacy.

Activity Type
Knowledge

Accreditation
Nurse N-634
Pharmacist 0798-0000-10-081-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education. In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on this website.
Pharmaceutical Education Consultants, Inc. has been approved as a provider of continuing education for nurses by the Maryland Nurses Association which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation.
Faculty
Mary Lynn McPherson , PharmD, BCPS, CDE
Professor, University of Maryland School of Pharmacy
Click Here For Curriculum Vitae


Financial Support By
Cephalon, Inc

Program Documents
Homestudy PDF: Breakthough Cancer Pain Handout